secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senseonics Holdings, Inc. (SENS)
CIK:        0001616543
Form:       8-K
Filed at:   2024-08-08T23:59:59+00:00
Accession:  0001104659-24-087268
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Q2 revenue $4.9M (+18% YoY), net loss $20.3M; 365-day Eversense Q4 launch on track
--------------------------------------------------------------------------------

- Q2 2024 revenue $4.9M, up 18% vs $4.1M in Q2 2023; U.S. revenue $3.0M (+67%), OUS $1.9M.
- Net loss $20.3M ($0.03/sh) vs $20.4M ($0.04/sh); gross profit slipped to $0.3M from $0.4M.
- FY 2024 revenue guidance unchanged at $22M-$24M; cash burn expected ~$70M, in line with 2023.
- FDA 510(k) review ongoing for 365-day Eversense; planned Q4 launch; Gemini System first-in-human testing began.
- Eon Care Services subsidiary formed; Mercy collaboration RPM service initial insertions expected Q3 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1616543/000110465924087268/0001104659-24-087268-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1616543/000110465924087268/tm2420870d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-087268

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer